Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis

AUTOR(ES)

Moliterno, Alison R.

FONTE

National Academy of Sciences

RESUMO

The chronic myeloproliferative disorders (MPD) are clonal hematopoietic stem cell disorders of unknown etiology. We have reported defective thrombopoietin receptor (Mpl) protein expression in MPD patients. To determine whether the basis of abnormal Mpl protein expression was due to mutations in the Mpl gene, we sequenced Mpl cDNA from MPD patients. We found a single nucleotide substitution (G1238T) that results in a change from lysine to asparagine at amino acid 39 (K39N) in three African-American women referred for an evaluation of an MPD. We subsequently screened more than 400 patients and controls and found that the K39N substitution is a polymorphism restricted to African Americans and that ≈7% of African Americans are heterozygous for K39N. African Americans with the K39N polymorphism had a significantly higher platelet count than controls without the polymorphism (P < 0.001) and reduced platelet protein Mpl expression. Expression of an Mpl cDNA containing the K39N substitution in cell lines was associated with incomplete processing and a reduction in Mpl protein, recapitulating the Mpl protein defect observed in platelets from individuals with K39N. K39N represents an identified functional Mpl polymorphism and is associated with altered protein expression of Mpl and a clinical phenotype of thrombocytosis.

Documentos Relacionados

• Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain
• Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin
• Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.
• Thrombopoietin is associated with a prognosis of gastric adenocarcinoma
• Löwy I. Imperfect pregnancies: a history of birth defects and prenatal diagnosis. Baltimore: Johns Hopkins University Press; 2017.